JP2024520805A5 - - Google Patents
Info
- Publication number
- JP2024520805A5 JP2024520805A5 JP2023575831A JP2023575831A JP2024520805A5 JP 2024520805 A5 JP2024520805 A5 JP 2024520805A5 JP 2023575831 A JP2023575831 A JP 2023575831A JP 2023575831 A JP2023575831 A JP 2023575831A JP 2024520805 A5 JP2024520805 A5 JP 2024520805A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- alzheimer
- disease
- antigen
- binding fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163209929P | 2021-06-11 | 2021-06-11 | |
| US63/209,929 | 2021-06-11 | ||
| US202163289081P | 2021-12-13 | 2021-12-13 | |
| US63/289,081 | 2021-12-13 | ||
| US202263321598P | 2022-03-18 | 2022-03-18 | |
| US63/321,598 | 2022-03-18 | ||
| PCT/US2022/033122 WO2022261510A1 (en) | 2021-06-11 | 2022-06-10 | Neuroactive steroid for the treatment of alzheimer's disease |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024520805A JP2024520805A (ja) | 2024-05-24 |
| JP2024520805A5 true JP2024520805A5 (https=) | 2025-06-30 |
Family
ID=82361350
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023575831A Pending JP2024520805A (ja) | 2021-06-11 | 2022-06-10 | アルツハイマー病の治療のための神経活性ステロイド |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20250319105A1 (https=) |
| EP (1) | EP4351588A1 (https=) |
| JP (1) | JP2024520805A (https=) |
| KR (1) | KR20240035444A (https=) |
| AU (1) | AU2022291395A1 (https=) |
| CA (1) | CA3223179A1 (https=) |
| IL (1) | IL309208A (https=) |
| MX (1) | MX2023014719A (https=) |
| WO (1) | WO2022261510A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3828194B1 (en) | 2015-07-06 | 2025-04-16 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| EP4704905A1 (en) * | 2023-05-02 | 2026-03-11 | Sage Therapeutics, LLC | Lymphatic system-targeting compounds |
| TW202508603A (zh) * | 2023-05-02 | 2025-03-01 | 美商賽吉醫療公司 | 神經活性類固醇調配物及其使用方法 |
| WO2025021195A1 (zh) * | 2023-07-27 | 2025-01-30 | 珂阑(上海)医药科技有限公司 | 甾类化合物、其制备方法和应用 |
| WO2025020190A1 (zh) * | 2023-07-27 | 2025-01-30 | 珂阑(上海)医药科技有限公司 | 甾类化合物、其制备方法和应用 |
| WO2025020191A1 (zh) * | 2023-07-27 | 2025-01-30 | 珂阑(上海)医药科技有限公司 | 甾类化合物、其制备方法和应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040132101A1 (en) | 2002-09-27 | 2004-07-08 | Xencor | Optimized Fc variants and methods for their generation |
| KR20080073293A (ko) | 2005-10-14 | 2008-08-08 | 메디뮨 엘엘씨 | 항체 라이브러리의 세포 디스플레이 |
| WO2008081008A1 (en) | 2007-01-05 | 2008-07-10 | University Of Zurich | Method of providing disease-specific binding molecules and targets |
| HRP20140049T1 (hr) | 2007-01-05 | 2014-02-28 | University Of Zürich | Anti beta-amiloid antitijela i njihova upotreba |
| HUE030100T2 (en) | 2010-02-19 | 2017-04-28 | Xencor Inc | New CTLA4-IG immunoadhesins |
| ES2758994T3 (es) | 2010-11-05 | 2020-05-07 | Zymeworks Inc | Diseño anticuerpo heterodimérico estable con mutaciones en el dominio Fc |
| CA2848212C (en) | 2011-09-08 | 2022-03-29 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| AP2014007606A0 (en) | 2011-10-07 | 2014-05-31 | Takeda Pharmaceutical | 1-Arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases |
| JP6249952B2 (ja) | 2012-10-16 | 2017-12-20 | 武田薬品工業株式会社 | 複素環化合物 |
| HUE039922T2 (hu) | 2012-12-11 | 2019-02-28 | Takeda Pharmaceuticals Co | Heterociklusos vegyületek |
| PT2968369T (pt) | 2013-03-13 | 2018-12-05 | Sage Therapeutics Inc | Esteroides neuroativos e métodos para o seu uso |
| JP6272833B2 (ja) | 2013-04-04 | 2018-01-31 | 武田薬品工業株式会社 | 複素環化合物 |
| EP3102230B1 (en) * | 2014-02-08 | 2021-04-28 | F. Hoffmann-La Roche AG | Methods of treating alzheimer's disease |
| US10259840B2 (en) | 2014-06-18 | 2019-04-16 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| MA41115A (fr) | 2014-12-02 | 2017-10-10 | Biogen Int Neuroscience Gmbh | Procédé de traitement de la maladie d'alzheimer |
| CA2991311C (en) | 2015-07-06 | 2025-05-06 | Sage Therapeutics, Inc. | OXYSTEROLS AND THEIR METHODS OF USE |
| EP3828194B1 (en) | 2015-07-06 | 2025-04-16 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| HUE071964T2 (hu) | 2015-07-06 | 2025-10-28 | Sage Therapeutics Inc | Oxiszterolok és alkalmazási eljárásaik |
| US10562881B2 (en) | 2015-10-16 | 2020-02-18 | Takeda Pharmaceutical Company Limited | Method for producing heterocyclic compound |
| SMT202200300T1 (it) | 2016-04-01 | 2022-09-14 | Sage Therapeutics Inc | Ossisteroli e relativi metodi d'uso |
| CA3021634A1 (en) | 2016-04-15 | 2017-10-19 | Zymeworks Inc. | Multi-specific antigen-binding constructs targeting immunotherapeutics |
| WO2017193046A1 (en) | 2016-05-06 | 2017-11-09 | Sage Therapeutics, Inc. | Oxysterols and methods of use thereof |
| ES2884071T3 (es) | 2016-07-07 | 2021-12-10 | Sage Therapeutics Inc | 24-hidroxiesteroles sustituidos en 11 para el tratamiento de afecciones relacionadas con NMDA |
| CA3038984A1 (en) | 2016-09-30 | 2018-04-05 | Schlumberger Canada Limited | Fiber measurements for fluid treatment processes in a well |
| RU2019115113A (ru) | 2016-10-18 | 2020-11-24 | Сейдж Терапьютикс, Инк. | Оксистеролы и способы их применения |
| TW202523658A (zh) | 2019-05-24 | 2025-06-16 | 美商賽吉醫療公司 | 化合物、組合物及使用方法 |
| WO2022115620A1 (en) | 2020-11-25 | 2022-06-02 | Sage Therapeutics, Inc. | 4-fluoro-(4-(4-benzyl)piperidin-1-yl)(2-(pyrimidin-4-yl)pyridin-3-yl)methanone derivatives and similar compounds as cyp46a1 inhibitors for the treatment of neurodegenerative disorders |
-
2022
- 2022-06-10 IL IL309208A patent/IL309208A/en unknown
- 2022-06-10 CA CA3223179A patent/CA3223179A1/en active Pending
- 2022-06-10 AU AU2022291395A patent/AU2022291395A1/en active Pending
- 2022-06-10 EP EP22736445.2A patent/EP4351588A1/en active Pending
- 2022-06-10 US US18/568,624 patent/US20250319105A1/en active Pending
- 2022-06-10 JP JP2023575831A patent/JP2024520805A/ja active Pending
- 2022-06-10 MX MX2023014719A patent/MX2023014719A/es unknown
- 2022-06-10 WO PCT/US2022/033122 patent/WO2022261510A1/en not_active Ceased
- 2022-06-10 KR KR1020247000634A patent/KR20240035444A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024520805A5 (https=) | ||
| JP7704815B2 (ja) | Ｂｃｍａに対する結合分子及びその使用 | |
| JP2020141669A5 (https=) | ||
| JP6916741B2 (ja) | 抗ｃｄ１９抗体およびブルトン型チロシンキナーゼ阻害剤の組み合わせ、およびその使用 | |
| US20110262525A1 (en) | Methods of treatment | |
| AU2017361549A1 (en) | Conjugated biological molecules, pharmaceutical compositions and methods | |
| US20150093398A1 (en) | Methods and Compositions for Treating or Preventing Cancer | |
| JP6862422B2 (ja) | 組み合わせおよびその使用 | |
| TW202417055A (zh) | 抗ｓｅｚ６抗體藥物接合物 | |
| JP2023025036A (ja) | がんの処置のためのアベルマブの投与レジメン | |
| US20250075007A1 (en) | Treatment of Al Amyloidosis with the Combination of Monoclonal Antibodies Agains Immunoglobulin Light Chains and the CD38 Cell Membrane Molecule on Antibody-Producing And Other Immune Cells | |
| US20220241412A1 (en) | Combination therapies using cdk inhibitors | |
| JP7352582B2 (ja) | Ｓｕｍｏ活性化酵素阻害剤及び抗ｃｄ２０抗体の投与 | |
| KR20220062030A (ko) | 다중-티로신 키나제 억제제 및 면역 관문 억제제를 포함하는 조합을 사용한 암의 치료 | |
| JP2021518348A5 (https=) | ||
| JP2020508353A (ja) | セリチニブ及び抗ｐｄ−１抗体分子の組合せのための投与スケジュール | |
| TW202310871A (zh) | 用莫蘇妥珠單抗及帕羅托珠單抗維多汀治療ｃｄ２０陽性增生性失調之方法 | |
| WO2021110122A1 (zh) | Cdk4/6抑制剂的组合疗法 | |
| WO2025148900A1 (en) | Combination therapy of grem1 antagonist and activin receptor antagonist for treating pah | |
| US20240207398A1 (en) | Methods and compositions for treating cancer | |
| US20260102490A1 (en) | Combination of trispecific antibody targeting bcma, gprc5d and cd3, and an anti-cd38 antibody for the treatment of multiple myeloma | |
| WO2025081048A1 (en) | Methods of treating cancer using anti-cd22 antibody oligonucleotide conjugates | |
| WO2026019990A1 (en) | Methods of treating cancer with anti-ccr8/anti-cd3 bispecific antibodies | |
| HK40119150A (zh) | 用於治疗癌症的方法和组合物 | |
| CN121889429A (zh) | 用于治疗嗜酸性肉芽肿性多血管炎的IL-5R-α抗体 |